Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The possible role of serum NGAL and MMP-9 in the assessment of kidney impairment and cardiovascular risk in children and adolescents with type 1 diabetes mellitus or obesity.
Kostopoulou E, Kalavrizioti D, Davoulou P, Plotas P, Sinopidis X, Papachristou E, Goumenos D, Dimitriou G, Spiliotis BE, Papasotiriou M. Kostopoulou E, et al. Among authors: kalavrizioti d. Eur Rev Med Pharmacol Sci. 2024 Nov;28(21):4536-4545. doi: 10.26355/eurrev_202411_36912. Eur Rev Med Pharmacol Sci. 2024. PMID: 39560929 Free article.
Soluble urokinase plasminogen activator receptor (suPAR) in children with obesity or type 1 diabetes as a marker of endothelial dysfunction: a cross-sectional study.
Kostopoulou E, Kalavrizioti D, Davoulou P, Sinopidis X, Papachristou E, Goumenos DS, Dimitriou G, Spiliotis BE, Papasotiriou M. Kostopoulou E, et al. Among authors: kalavrizioti d. Eur J Pediatr. 2024 May;183(5):2383-2389. doi: 10.1007/s00431-024-05496-5. Epub 2024 Mar 7. Eur J Pediatr. 2024. PMID: 38448612
Monocyte Chemoattractant Protein-1 (MCP-1), Activin-A and Clusterin in Children and Adolescents with Obesity or Type-1 Diabetes Mellitus.
Kostopoulou E, Kalavrizioti D, Davoulou P, Papachristou E, Sinopidis X, Fouzas S, Dassios T, Gkentzi D, Kyriakou SI, Karatza A, Dimitriou G, Goumenos D, Spiliotis BE, Plotas P, Papasotiriou M. Kostopoulou E, et al. Among authors: kalavrizioti d. Diagnostics (Basel). 2024 Feb 19;14(4):450. doi: 10.3390/diagnostics14040450. Diagnostics (Basel). 2024. PMID: 38396489 Free PMC article.
Ghrelin, glucagon-like peptide-1, and peptide YY secretion in patients with and without weight regain during long-term follow-up after bariatric surgery: a cross-sectional study.
Lampropoulos C, Mulita F, Alexandrides T, Kehagias D, Kalavrizioti D, Albanopoulos K, Georgopoulos N, Papachristou E, Kehagias I. Lampropoulos C, et al. Among authors: kalavrizioti d. Prz Menopauzalny. 2022 Jun;21(2):97-105. doi: 10.5114/pm.2022.116492. Epub 2022 Jun 8. Prz Menopauzalny. 2022. PMID: 36199737 Free PMC article.
Biomarkers in Progressive Chronic Kidney Disease. Still a Long Way to Go.
Ntrinias T, Papasotiriou M, Balta L, Kalavrizioti D, Vamvakas S, Papachristou E, Goumenos DS. Ntrinias T, et al. Among authors: kalavrizioti d. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019 Dec 1;40(3):27-39. doi: 10.2478/prilozi-2020-0002. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019. PMID: 32109222 Free article. Review.
The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial.
Oikonomaki T, Papasotiriou M, Ntrinias T, Kalogeropoulou C, Zabakis P, Kalavrizioti D, Papadakis I, Goumenos DS, Papachristou E. Oikonomaki T, et al. Among authors: kalavrizioti d. Int Urol Nephrol. 2019 Nov;51(11):2037-2044. doi: 10.1007/s11255-019-02275-2. Epub 2019 Sep 17. Int Urol Nephrol. 2019. PMID: 31529295 Clinical Trial.
Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study.
Provatopoulou S, Kalavrizioti D, Stangou M, Kouri MN, Kalliakmani P, Papasotiriou M, Papachristou E, Goumenos DS, Papagianni A. Provatopoulou S, et al. Among authors: kalavrizioti d. Rom J Intern Med. 2019 Jun 1;57(2):141-150. doi: 10.2478/rjim-2018-0044. Rom J Intern Med. 2019. PMID: 30864406 Free article.
ERβ-Dependent Direct Suppression of Human and Murine Th17 Cells and Treatment of Established Central Nervous System Autoimmunity by a Neurosteroid.
Aggelakopoulou M, Kourepini E, Paschalidis N, Simoes DC, Kalavrizioti D, Dimisianos N, Papathanasopoulos P, Mouzaki A, Panoutsakopoulou V. Aggelakopoulou M, et al. Among authors: kalavrizioti d. J Immunol. 2016 Oct 1;197(7):2598-609. doi: 10.4049/jimmunol.1601038. Epub 2016 Aug 22. J Immunol. 2016. PMID: 27549171
25 results